QTTB Q32 Bio Inc.
$8.71▲ +3.08%
Healthcare
Other
Volume 692.6K
Avg Volume (10D) 568.2K
Key Metrics & Fundamentals
Market Cap
$259.29M
P/E Ratio
2.7
Div Yield
0.00%
52W Range
1.91 - 23.57
% vs 50 MA
-19.73%
% vs 200 MA
-4.86%
RSI-14
45.4
MACD Histogram
+0.2600
Beta (1Y vs SPY)
0.00
Free Cash Flow
-$3.08M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$8.89M
COGS
–
Operating Exp
$9.12M
Operating Income
-$9.12M
EBIT
-$9.12M
Pretax Income
-$8.95M
Net Income
-$8.95M
EPS (Diluted)
-0.44
Price & Volume History
Loading chart…
Recent News
This Biotech Had Good News for Hair Loss Sufferers. So Why Is the Stock Sinking?
Barrons.com · Oct 1, 2026 12:23 PM ET
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
PR Newswire · Sep 30, 2026 9:15 AM ET
Top Premarket Gainers
MT Newswires · Sep 30, 2026 7:15 AM ET
Top Premarket Gainers
MT Newswires · Sep 29, 2026 7:12 AM ET
Jefferies Initiates Q32 Bio at Buy With $29 Price Target
MT Newswires · Sep 28, 2026 6:43 AM ET
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026
PR Newswire · Sep 21, 2026 9:15 AM ET
Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
PR Newswire · Sep 14, 2026 6:59 AM ET
Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround
Zacks · Sep 7, 2026 9:35 AM ET
These 2 ‘Monster Growth’ Stocks Aren’t Done Climbing, Say Analysts
TipRanks · Sep 6, 2026 2:00 PM ET
Q32 Bio to Participate in Upcoming September Investor Conferences
PR Newswire · Sep 1, 2026 6:59 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See QTTB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.